deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04619472

Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors (BRONC-RFⅡ)

A Multicenter, Single Group Target Value Clinical Study to Evaluate Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors

Sponsor: Hangzhou Broncus Medical Co., Ltd.

Conditions Lung Neoplasms Pulmonary Metastasis
Interventions Pulmonary Radiofrequency Ablation System and the Disposable Pulmonary Radiofrequency Ablation Catheter
Updated 9 times since 2020 Last updated: Dec 19, 2023 Started: Jan 7, 2021 Primary completion: Oct 24, 2022 Completion: Mar 27, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lung Neoplasms and Pulmonary Metastasis and is currently completed. Hangzhou Broncus Medical Co., Ltd. leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2021 – ~Nov 2021 · 9 months · monthly snapshotRecruiting~Nov 2021 – ~Feb 2023 · 15 months · monthly snapshotRecruiting~Feb 2023 – ~May 2023 · 3 months · monthly snapshotUnknown Status~May 2023 – ~Jan 2024 · 8 months · monthly snapshotActive Not Recruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2024 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  4. May 2023 — Jan 2024 [monthly]

    Active Not Recruiting NA

    Status: Unknown Status → Active Not Recruiting

  5. Feb 2023 — May 2023 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

  1. Nov 2021 — Feb 2023 [monthly]

    Recruiting NA

  2. Feb 2021 — Nov 2021 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting NA

  4. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hangzhou Broncus Medical Co., Ltd.
Data source: Hangzhou Broncus Medical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations